176 related articles for article (PubMed ID: 8382116)
1. Comparison in C3H and C3B6F1 mice of the sensitivity to diethylnitrosamine-initiation and phenobarbital-promotion to the extent of cell proliferation.
Pereira MA
Carcinogenesis; 1993 Feb; 14(2):299-302. PubMed ID: 8382116
[TBL] [Abstract][Full Text] [Related]
2. Strain differences in hepatic tumor promotion by phenobarbital in diethylnitrosamine- and dimethylnitrosamine-initiated infant male mice.
Weghorst CM; Pereira MA; Klaunig JE
Carcinogenesis; 1989 Aug; 10(8):1409-12. PubMed ID: 2752514
[TBL] [Abstract][Full Text] [Related]
3. Phenobarbital promotion in diethylnitrosamine-initiated infant B6C3F1 mice: influence of gender.
Weghorst CM; Klaunig JE
Carcinogenesis; 1989 Mar; 10(3):609-12. PubMed ID: 2924405
[TBL] [Abstract][Full Text] [Related]
4. Effect of phenobarbital on the development of liver tumors in juvenile and adult mice.
Pereira MA; Klaunig JE; Herren-Freund SL; Ruch RJ
J Natl Cancer Inst; 1986 Aug; 77(2):449-52. PubMed ID: 3461205
[TBL] [Abstract][Full Text] [Related]
5. Effect of the age of B6C3F1 mice on phenobarbital promotion of diethylnitrosamine-initiated liver tumors.
Klaunig JE; Weghorst CM; Pereira MA
Toxicol Appl Pharmacol; 1987 Aug; 90(1):79-85. PubMed ID: 3629593
[TBL] [Abstract][Full Text] [Related]
6. Dose-response relationship of diethylnitrosamine-initiated tumors in neonatal balb/c mice: effect of phenobarbital promotion.
Klaunig JE; Pereira MA; Ruch RJ; Weghorst CM
Toxicol Pathol; 1988; 16(3):381-5. PubMed ID: 3194660
[TBL] [Abstract][Full Text] [Related]
7. Interstrain differences in susceptibility to liver carcinogenesis initiated by N-nitrosodiethylamine and its promotion by phenobarbital in C57BL/6NCr, C3H/HeNCrMTV- and DBA/2NCr mice.
Diwan BA; Rice JM; Ohshima M; Ward JM
Carcinogenesis; 1986 Feb; 7(2):215-20. PubMed ID: 3948311
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of acute and subacute treatment of phenobarbital in different strains of mice.
Lin EL; Klaunig JE; Mattox JK; Weghorst CM; McFarland BH; Pereira MA
Cancer Lett; 1989 Nov; 48(1):43-51. PubMed ID: 2819695
[TBL] [Abstract][Full Text] [Related]
9. Effect of phenobarbital on diethylnitrosamine and dimethylnitrosamine induced hepatocellular tumors in male B6C3F1 mice.
Klaunig JE; Weghorst CM; Pereira MA
Cancer Lett; 1988; 42(1-2):133-9. PubMed ID: 3180032
[TBL] [Abstract][Full Text] [Related]
10. Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice.
Ward JM; Rice JM; Creasia D; Lynch P; Riggs C
Carcinogenesis; 1983 Aug; 4(8):1021-9. PubMed ID: 6872148
[TBL] [Abstract][Full Text] [Related]
11. Effect of coadministration of phenobarbital sodium on N-nitrosodiethylamine-induced gamma-glutamyltransferase-positive foci and hepatocellular carcinoma in rats.
Pereira MA; Herren-Freund SL; Britt AL; Khoury MM
J Natl Cancer Inst; 1984 Mar; 72(3):741-4. PubMed ID: 6142138
[TBL] [Abstract][Full Text] [Related]
12. Chemoprevention of diethylnitrosamine-induced liver foci and hepatocellular adenomas in C3H mice.
Pereira MA
Anticancer Res; 1995; 15(5B):1953-6. PubMed ID: 8572583
[TBL] [Abstract][Full Text] [Related]
13. Cell proliferation and regulation of negative growth factors in mouse liver foci.
Moser GJ; Wolf DC; Harden R; Standeven AM; Mills J; Jirtle RL; Goldsworthy TL
Carcinogenesis; 1996 Sep; 17(9):1835-40. PubMed ID: 8824503
[TBL] [Abstract][Full Text] [Related]
14. Quantitation of the cancer process in C57BL/6J, B6C3F1 and C3H/HeJ mice.
Goldsworthy TL; Fransson-Steen R
Toxicol Pathol; 2002; 30(1):97-105. PubMed ID: 11890483
[TBL] [Abstract][Full Text] [Related]
15. The inhibition by methionine and choline of liver carcinoma formation in male C3H mice dosed with diethylnitrosamine and fed phenobarbital.
Fullerton FR; Hoover K; Mikol YB; Creasia DA; Poirier LA
Carcinogenesis; 1990 Aug; 11(8):1301-5. PubMed ID: 2387015
[TBL] [Abstract][Full Text] [Related]
16. Quantitative relationship between transforming growth factor-alpha and hepatic focal phenotype and progression in female mouse liver.
Moser GJ; Wolf DC; Goldsworthy TL
Toxicol Pathol; 1997; 25(3):275-83. PubMed ID: 9210259
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of the paradoxical, inhibitory effect of phenobarbital on hepatocarcinogenesis initiated in infant B6C3F1 mice with diethylnitrosamine.
Lee GH; Ooasa T; Osanai M
Cancer Res; 1998 Apr; 58(8):1665-9. PubMed ID: 9563480
[TBL] [Abstract][Full Text] [Related]
18. Incorporation of bromodeoxyuridine in glutathione S-transferase-positive hepatocytes during rat multistage hepatocarcinogenesis.
Dragan YP; Hully J; Crow R; Mass M; Pitot HC
Carcinogenesis; 1994 Sep; 15(9):1939-47. PubMed ID: 7923588
[TBL] [Abstract][Full Text] [Related]
19. Rapid development of hepatic tumors in transforming growth factor alpha transgenic mice associated with increased cell proliferation in precancerous hepatocellular lesions initiated by N-nitrosodiethylamine and promoted by phenobarbital.
Tamano S; Merlino GT; Ward JM
Carcinogenesis; 1994 Sep; 15(9):1791-8. PubMed ID: 7923571
[TBL] [Abstract][Full Text] [Related]
20. Effect of the separate and combined administration of mestranol and phenobarbital on the development of altered hepatic foci expressing placental form of glutathione S-transferase in the rat.
Dragan YP; Singh J; Pitot HC
Carcinogenesis; 1996 Sep; 17(9):2043-52. PubMed ID: 8824533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
